newsfilter
← Latest News
PR Newswire·

Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

HERZLIYA, Israel and CALGARY, AB, May 1, 2023 /CNW/ -- Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF) (the "Company" or "Innocan") is pleased to announce the entering into of a wide-scope